AAAAAA
Results:
1-11
|
Results: 11
Authors:
Chiamvimonvat, V
Goodman, SG
Langer, A
Barr, A
Freeman, MR
Citation: V. Chiamvimonvat et al., Prognostic value of dipyridamole SPECT imaging in low-risk patients after myocardial infarction, J NUCL CARD, 8(2), 2001, pp. 136-143
Authors:
Goodman, SG
Citation: Sg. Goodman, Low-molecular-weight heparin in patients with non-ST-segment elevation acute coronary syndrome: role in the emergency department. (vol 19, pg 3, 2000), J EMERG MED, 20(1), 2001, pp. 105-105
Authors:
Kaul, P
Fu, YL
Chang, WC
Harrington, RA
Wagner, GS
Goodman, SG
Granger, CB
Moliterno, DJ
Van de Werf, F
Califf, RN
Topol, EJ
Armstrong, PW
Citation: P. Kaul et al., Prognostic value of ST segment depression in acute coronary syndromes: Insights from PARAGON-A applied to GUSTO-IIb, J AM COL C, 38(1), 2001, pp. 64-71
Authors:
Goodman, SG
Langer, A
Citation: Sg. Goodman et A. Langer, Enoxaparin for acute coronary syndromes? Reply, J AM COL C, 37(7), 2001, pp. 2007-2008
Authors:
Goodman, SG
Citation: Sg. Goodman, Low-molecular-weight heparin in patients with non-ST-segment elevation acute coronary syndrome: Role in the emergency department, J EMERG MED, 19(3), 2000, pp. 3S-11S
Authors:
Goodman, SG
Barr, A
Sobtchouk, A
Cohen, M
Fromell, GJ
Laperriere, L
Hill, C
Langer, A
Citation: Sg. Goodman et al., Low molecular weight heparin decreases rebound ischemia in unstable anginaor non-Q-wave myocardial infarction: The Canadian ESSENCE ST segment monitoring substudy, J AM COL C, 36(5), 2000, pp. 1507-1513
Authors:
Goodman, SG
Cohen, M
Bigonzi, F
Gurfinkel, EP
Radley, DR
Le Iouer, V
Fromell, GJ
Demers, C
Turpie, AGG
Califf, RM
Fox, KAA
Langer, A
Citation: Sg. Goodman et al., Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease - One-year results of the ESSENCE study, J AM COL C, 36(3), 2000, pp. 693-698
Authors:
Barbagelata, A
Califf, RM
Sgarbossa, EB
Goodman, SG
Knight, D
Mark, DB
Granger, CB
Agranatti, DA
Mautner, B
Ohman, EM
Suarez, LD
Armstrong, PW
Gates, K
Wagner, GS
Citation: A. Barbagelata et al., Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial), AM J CARD, 86(1), 2000, pp. 24-29
Authors:
Sgarbossa, EB
Meyer, PM
Pinski, SL
Pavlovic-Surjancev, B
Barbagelata, A
Goodman, SG
Lum, AS
Underwood, DA
Gates, KB
Califf, RM
Topol, EJ
Wagner, GS
Citation: Eb. Sgarbossa et al., Negative T waves shortly after ST-elevation acute myocardial infarction are a powerful marker for improved survival rate, AM HEART J, 140(3), 2000, pp. 385-394
Authors:
Cohen, M
Stinnett, SS
Weatherley, BD
Gurfinkel, EP
Fromell, GJ
Goodman, SG
Fox, KAA
Califf, RM
Citation: M. Cohen et al., Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy, AM HEART J, 139(6), 2000, pp. 962-970
Authors:
Sgarbossa, EB
Pinski, SL
Barbagelata, A
Goodman, SG
Natale, A
Gates, KB
Wagner, GS
Citation: Eb. Sgarbossa et al., ECG subanalyses in clinical trials: An investigator's perspective, J ELCARDIOL, 32, 1999, pp. 114-121
Risultati:
1-11
|